Transcription of nCoV template PPT GEN PUB
{{id}} {{{paragraph}}}
Example: bachelor of science
nCoV template PPT GEN PUB
Framework:Pfizer-BioNTech COVID-19 vaccine in children aged 5 11 yearsSara Oliver MD, MSPHACIP MeetingNovember 2, 2021 Evidence to Recommendations (EtR) Framework Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, 10 g, IM) be recommended for children 5 11 years of age, under an Emergency Use Authorization?Evidence to Recommendations (EtR) FrameworkPolicy QuestionPopulationChildren aged 5 11 yearsInterventionPfizer-BioNTech COVID-19 vaccine (BNT162b2)(2-d o s e s , 1 0 g , IM)ComparisonNo vaccineOutcomesSymptomatic laboratory-confirmed COVID-19 Hospitalization due to COVID-19 Multisystem inflammatory syndrome in children (MIS-C)Asymptomatic SARS-CoV-2 infectionSerious adverse eventsReactogenicity grade 3 Evidence to Recomm
Nov 02, 2021 · Wide use of an effective vaccine would reduce public health burden of COVID-19 in children 5– 11 years of age. Public Health Problem. Work Group Interpretation. Is COVID-19 disease among children aged 5–11 years of public health importance? o. No. o. Probably no. o. Probably yes. o. Yes. o. Varies. o.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: